The author explores the significant pharmacokinetic and pharmacodynamic heterogeneity of current antidepressants and reviews the many potential drug targets that exist—with a focus on the serotonin system.
John J. Miller, MD
This article focuses on the various classes of antidepressants and how they have evolved.
Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.
This article reviews the reasons for measuring serum levels of psychotropics and provides optimum serum levels for various psychotropic agents to optimize their effectiveness and safety.
Most often, psychiatric medications are discontinued unilaterally by the patient, without the psychiatrist’s input or consent. Setting the stage early with a discussion about medication discontinuation is time well spent. More in this CME.